Suministro de medicamentos de uso humano de fabricación industrial biológicos/biosimilares bevacizumab, etanercept, infliximab, filgrastim y pegfilgrastim, para...
€66,000
Award value
111 contracts won, worth €3.6M, from 22 public buyers.
Main sectors Medical equipment & pharmaceuticals 29
We email you when this company wins a new contract. Free, one click to stop.
Record
Each dot is one award, placed on its date and sized by its value. Where a year holds more than 80 awards, its 80 largest are drawn.
Relations
Shares of the 111 contracts this company has won.
Radar
Contracts this company holds that end within the next two years. The specification for the replacement is usually shaped 18 to 26 months before the notice appears.
€300,000 current contract
1 month
Nov 2026
€427,798 current contract
1 month
Dec 2026
Prices
€11,193
over 111 awards with a published amount
At estimate
typical award, over 109 contracts with both figures
1 month
median, over 29 contracts with a known length
Territory
Shares of the 111 contracts that name a region.
Register
Each bar compares an award with the largest on this page, €300,000.
€66,000
Award value
€2,134
Award value
3.8% under estimate
€2,749
Award value
€1,920
Award value
€3,200
Award value
€68,495
Award value
€24,055
Award value
€259,200
Award value
€300,000
Award value
4.0% over estimate
€66
Award value
3.9% under estimate
€190
Award value
€14,944
Award value
€14,922
Award value
€14,961
Award value
€7,122
Award value
€9,029
Award value
€9,197
Award value
€12,038
Award value
€14,922
Award value
€5,631
Award value